AzTrials
AzTrials

Condition

Dementia Clinical Trials

Studies of dementia, matched by condition name and medical subject headings. Start with those open to enrolment.

6,686 registered studies

In numbers

Open to volunteers
1,348
Active
1,618
With results posted
1,099
All registered
6,686

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 1,348
  • Huntington Disease, Sarcopenia

    Creatine and Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation Plus Home-Based Exercise for Sarcopenia in Huntington's Disease

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    Huntington's disease (HD) is a rare neurodegenerative disorder in which accelerated loss of muscle mass, strength and autonomy (physical frailty and sarcopenia) contributes to functional decline.

    Conditions
    Huntington Disease, Sarcopenia, Frailty
    Trial name
    SARCO-HD (NCT07902206)
    Testing
    Creatine monohydrate, Beta-hydroxy-beta-methylbutyrate (HMB), Home-based multicomponent exercise program
    Where
    Spain
    Volunteers
    88 people
    Sponsor
    Universidad de Burgos
    Can I take part? SARCO-HD
  • Alzheimer's Disease

    Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

    • Recruiting
    • Age: 65 to 120 years
    • Phase 2

    Background: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking.

    Trial name
    NCT07721467
    Testing
    Psilocybin, Cognitive Training
    Where
    United States
    Volunteers
    200 people, healthy volunteers welcome
    Sponsor
    National Institute on Aging (NIA)
    Can I take part? NCT07721467
  • Alzheimer's Disease (AD), Dementia

    Negotiation Training for Family Caregivers of People With Alzheimer's Disease

    • Not yet recruiting
    • Age: 21 years and older
    • Lifestyle or therapy programme

    Family caregivers of people living with Alzheimer's disease and related dementias often experience conflicts and communication challenges when coordinating care, making decisions, and interacting with family members and…

    Conditions
    Alzheimer's Disease (AD), Dementia, Cognitive Impairment
    Trial name
    NCT07859540
    Testing
    NegotiAge, PlanYourLifespan
    Where
    United States
    Volunteers
    200 people, healthy volunteers welcome
    Sponsor
    Northwestern University
    Can I take part? NCT07859540
  • Huntington Disease

    Pridopidine Phase 3 Study in Huntington's Disease

    • Recruiting
    • Age: 23 to 65 years
    • Phase 3

    The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine.

    Trial name
    PRECISE-HD (NCT07609108)
    Testing
    Pridopidine
    Where
    66 sites in United States, Belgium and 10 more
    Volunteers
    400 people
    Sponsor
    Prilenia
    Can I take part? PRECISE-HD
  • Aging

    Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging

    • Recruiting
    • Age: 55 to 110 years
    • Observational study

    Background: Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other mental abilities.

    Trial name
    NCT07099053
    Where
    United States
    Volunteers
    400 people, healthy volunteers welcome
    Sponsor
    National Institute on Aging (NIA)
    Can I take part? NCT07099053
  • Rare Disorders, Undiagnosed Disorders

    Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

    • Recruiting
    • Age: All ages
    • Observational study

    The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research.

    Conditions
    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence, Cornelia De Lange Syndrome
    Trial name
    CoRDS (NCT01793168)
    Where
    United States
    Volunteers
    20,000 people
    Sponsor
    Sanford Health
    Can I take part? CoRDS
  • Apathy, Brain Stimulation

    Network-based tDCS for Apathy

    • Not yet recruiting
    • Age: 65 years and older
    • Medical device

    Apathy is one of the most common and undertreated neurobehavioral symptoms in older adults with dementia. It is associated with reduced motivation and engagement in daily activities, and may contribute to faster cognitive and…

    Conditions
    Apathy, Brain Stimulation, Dementia
    Trial name
    NCT07900191
    Testing
    transcranial direct current stimulation
    Volunteers
    20 people
    Sponsor
    Hebrew SeniorLife
    Can I take part? NCT07900191
  • Alzheimer Disease, Dementia

    A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Recruiting
    • Age: 55 years and older
    • Phase 3

    The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

    Conditions
    Alzheimer Disease, Dementia, Plaque, Amyloid
    Trial name
    NCT07602582
    Testing
    Donanemab
    Where
    62 sites in United States, Japan and 1 more
    Volunteers
    550 people
    Sponsor
    Eli Lilly and Company
    Can I take part? NCT07602582
  • Healthy Adult, Flushing

    ALDH2 Genetic Testing in East Asian Community

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn whether education plus genetic testing for ALDH2*2 and ADH1B*2 is feasible and acceptable and whether it influences modifiable health behaviors in East Asian American adults who…

    Trial name
    NCT07392775
    Testing
    Genetic Test Results Return, Alcohol Flushing Education
    Where
    United States
    Volunteers
    100 people, healthy volunteers welcome
    Sponsor
    Northwestern University
    Can I take part? NCT07392775
  • Parkinson's Disease (PD), Multiple System Atrophy (MSA)

    [18F]ACI-15916 PET in α-synucleinopathies

    • Recruiting
    • Age: 20 years and older
    • Early Phase 1

    The goal of this clinical trial is to test whether we can reliably and safely measure the accumulation of pathological protein α-synuclein [involved in some diseases such as Parkinson's disease, Lewy body dementia and Multiple…

    Conditions
    Parkinson's Disease (PD), Multiple System Atrophy (MSA), Dementia With Lewy Bodies (DLB)
    Trial name
    NCT06891703
    Testing
    [18F]ACI-15916
    Where
    Sweden
    Volunteers
    46 people, healthy volunteers welcome
    Sponsor
    AC Immune SA
    Can I take part? NCT06891703

Completed, with results posted

All 944

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in